Clinical Studies
        (Click following titles for corresponding clinical report)


        A. KLT Application in the Treatment of Non-Small Cell Lung Cancer (NSCLC)
        1.Summary of Phase III Clinical Trial of Kanglaite Injection in the Treatment of Primary Bronchogenic Pulmonary Carcinoma
        2. A Phase III Clinical Study of Kanglaite Injection Combined with Chemotherapy (PVM Scheme) in the Treatment of Non-Small Cell Lung Cancer (NSCLC)
        3. Phase III Clinical Trial on Kanglaite Injection Combined with Surgical Operation in the Treatment of Primary Pulmonary Carcinoma
        4. Clinical Trial of Kanglaite Injection in Patients with NSCLC in Russia
        5. Experience and Comprehension from the Treatment of NSCLC with KLT in Russia
        6. Dynamics of Immunological Status in Patients with Lung Cancer Treated with Kanglaite Injection
        7. Study I: Phase II Study of KLT Injection in Patients with Advanced NSCLC
        8. Study II: Kanglaite Injection Combined with GEM and DDP in Treating NSCLC
        9. Kanglaite Injection (KLT) in the Treatment of Chemotherapy Inefficacious Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
        10. A Comparative Study on Efficacy and Adverse Reaction of MVP and MVP Combined with Kanglaite Injection in the Treatment of Non-Small Cell Lung Cancer (NSCLC) 
        11. Clinical Study on the Treatment of Non-Small Cell Lung Cancer (NSCLC) with a Combined Therapy of Kanglaite Injection and Chemotherapy 
        12. Therapeutic Observation on Kanglaite Injection Combined with Chemotherapy in the Treatment of  Advanced NSCLC 
        13. Combination of Kanglaite Injection and CAP Regimen Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer 
        14. Clinical Observation on Kanglaite Injection Combined with Chemotherapy in Treating Elderly Patients with NSCLC 
        15. Combination of Kanglaite Injection and NVB-IFO Chemotherapy in the Treatment of Non-Small Cell Lung Cancer 
        16. Clinical Observation on Kanglaite Injection Combined with EP Regimen in Treating Advanced NSCLC 
        17. Clinical Observation on Kanglaite Injection Combined CEP Regimen in Treating NSCLC 
        18. Clinical Observation on Kanglaite Injection in Combination with MVP Regimen to Treat 40 Advanced NSCLC Patients 
        19. Clinical Observation on Kanglaite Injection Combined with HEP Regimen in the Treatment of Advanced NSCLC 
        20. Clinical Observation on KLT Combined with NIC in the Treatment of Advanced NSCLC
        21. Clinical Analysis of Kanglaite Injection in the Treatment of Advanced Lung Cancer 
        22. Clinical Observation on the Efficacy of Kanglaite Injection (KLT) Combined with NVB + PDD Regimen in the Treatment of Advanced NSCLC
        23. Clinical Observation on Kanglaite Injection Combined with HAP Regimen in the Treatment of Mid- and Late-Stage Lung Cancer
        24. Effect of Kanglaite Injection (KLT) on Quality of Life of Senile Patients with NSCLC Treated with Chemotherapy 
        25. Clinical Observation on Kanglaite Injection Combined with Chemotherapy in the Treatment of Mid or Late Stage NSCLC 
        26. Clinical Observation on Kanglaite Injection Combined with Docetaxel in the Treatment of Recurrent Advanced NSCLC
        27. Clinical Analysis on Postoperative Complications of Stage IIIa Non-Small-Cell Lung Cancer Treated by Kanglaite Injection Combined with Neoadjuvant Chemotherapy
        28. Clinical Effect of Kanglaite Injection Combined with Paclitaxel in the Management of Aged Patients with Advanced NSCLC
        29. Clinical Study on Combination of Kanglaite Injection, IFNα and Megestrol Acetate in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
        30.  Analysis on Immunological Indexes of 95 Cases with Primary Bronchogenic Carcinoma Treated by Kanglaite Injection
        31. Kanglaite Injection in Combination with Navelbine and Cisplatin in Treating Patients with Intermediated and Advanced Non-Small Cell Lung Cancer
        32. Clinical Study on Kanglaite Injection Combined with Intervention Chemotherapy in the Treatment of Primary Hepatic Carcinoma and Primary Pulmonary Carcinoma
        33. The Application of Kanglaite Injection (KLT) in Palliative Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
        34. Effect of Kanglaite Injection combined with chemotherapy in treating advanced non-small-cell lung cancer

        B. KLT Application in the Treatment of Primary Hepatic Cancer
        1. Summary of Phase III Clinical Study of Kanglaite Injection in Treating Primary Hepatic Carcinoma
        2. Clinical Study on Kanglaite Injection Combined with Arterial Perfusion of Chemotherapeutic Drugs in the Treatment of Metastatic Liver Cancer
        3. Therapeutic Observation of Kanglaite Injection (KLT) in Supporting Intervention Therapy to Liver Cancer – 38 Cases Reports
        4. Experimental Studies on Potentiation Effect of KLT Injection on Chemotherapy of Hepatic Carcinoma
        5. Effect of Kanglaite in a Multidisciplinary and Comprehensive Treatment of Primary Hepatic Carcinoma
        6. Analysis on therapeutic effect of Kanglaite Injection in treating advanced hepatic carcinoma
        7. Observation on therapeutic effect of Kanglaite Injection combined with transcatheter arterial chemoembolization (TACE) in treating mid-late stage liver cancer
        8. Effect observation on intravenous drip of Kanglaite Injection combined with ultrasound thermal therapy in the treatment of patients with advanced hepatic carcinoma
        9. Clinical observation on effect of Kanglaite Injection combined with chemoembolization in treating primary middle and late stage liver cancer
        10. Kanglaite Injection combined with TAE in treating mid-late stage hepatic carcinoma
        11. Effects of transcatheter arterial chemoembolization combined with Kanglaite Injection on patients with advanced unresectable hepatocellular carcinoma
        12. Effects of DCRT Combined with Kanglaite Injection on Patients with Advanced Unresectable Hepatocellular Carcinoma
        13. Effects of intervention therapy combined with Kanglaite Injection on patients with advanced unresectable hepatocellular carcinoma
        14. Effects of Kanglaite Injection combined with Capecitabine on Patients with Advanced Unresectable Hepatocellular Carcinoma
        15. The application of Kanglaite Injection (KLT) combining with small-dose somatostatin in treating advanced hepatic carcinoma
        16. The effect of Kanglaite Injection (KLT) on immune function in patients with advanced primary hepatocarcinoma
        17. Application of Kanglaite Injection (KLT) in treating advanced hepatic caner (57 cases)
        18. Study on impact of Kanglaite Injection (KLT) on life of quality of advanced hepatic carcinoma patient
        19. Effects of kanglaite capsules combined with transcatheter arterial chemoembolization (TACE) on patients with mid or late-stage primary hepatocellular carcinoma (HCC)
         
        C. KLT Application in the Treatment of Non Hodgkin's Lymphoma (NHL)
        1. Clinical Observation on Kanglaite Injection Combined with Chemotherapy in Treating Non Hodgkin's Lymphoma (NHL)
        2. Clinical Observation of Kanglaite Injection Combined with EPOCH Regimen to Treat Relapsed or Resistant Advanced Non-Hodgkin's Lymphoma
        3. Clinical Observation on Combined Treatment of Kanglaite Injection with Chemotherapy for Non Hodgkin Lymphoma in Mid and Advanced Stages
        4. Kanglaite Injection plus Mitoxantrone in the Treatment of 20 Cases of Mailignant Lymphoma
        5. Kanglaite Injection Combined with Chemotherapy & Radiotherapy in Treating Non-Hodgkin’s Lymphoma
         
        D. KLT Application in the Treatment of Other Tumors
        1. Kanglaite Injection plus 5-fluorouracil, Cisplatin and in Combination with Radiotherapy in the Treatment of Advanced Pancreatic Cancer
        2. Clinical Observation on Kanglaite Injection Combined with Small-Dose of Cisplatin and 5-FU in the Treatment of Advanced Pancreatic Cancer
        3. Clinical Observation on Kanglaite Injection Combined with Chemotherapy in the Treatment of Metastatic Breast Cancer
        4. Observation on Clinical Effect of Kanglaite Injection (KLT) in the Treatment of Primary Mammary Cancer
        5. Clinical Observation on Kanglaite Injection (KLT) Combined with DF Scheme in the Treatment of Esophageal Cancer
        6. Safety and Effect of Kanglaite Injection Combined with Radiation Therapy in the Treatment of Patients Aged 75 and above with Inoperable Esophageal Carcinoma
        7. Therapeutic Observation on Kanglaite Injection Combined with Chemotherapy in the Treatment of 24 Cases with Esophageal Carcinoma 
        8. Impact of KLT on Therapeutic Effect of Radiotherapy in Treating Advanced Naso-pharyngeal Carcinoma
        9. Preliminary Study on Preventive Effect of Kanglaite Injection on Remote Metastasis of Cervical Lymph Nodes N2, N3 Nasopharyngeal
        10. Therapeutic Effect of Kanglaite Injection Combined with Radiotherapy in the Management of Nasopharyngeal Carcinoma among Aged Patients
        11. Kanglaite Injection Combined with Chemotherapy in the Treatment of Advanced Colorectal Cancer
        12. Clinical observance on Kanglaite Injection (KLT) combining with concurrent radio- and chemo-therapy in treating local recurrence of post-operative rectal cancer
        13. Therapeutic Observation of Kanglaite Injection (KLT) in the Treatment of 30 Cases of Advanced Tumor in Digestive System   
        14. Therapeutic Observation on Kanglaite Injection in the Treatment of 52 Cases with Advanced Malignant Tumor in Digestive System
        15. Evaluation on Short-term Efficacy and Toxicity of KLT Combined Chemotherapy in Treating Patients with Advanced Carcinoma of Digestive Tract
        16. Observation on the Effect of Kanglaite Injection in the Treatment of Advanced Renal Carcinoma
        17. Observation on the Effect of Kanglaite Injection Combined with Chemotherapy in the Treatment of Gastric Cancer
        18. Pathological study on effect of Kanglaite Injection on cervical cancer
        19. Clinical Observation on Kanglaite Injection (KLT) in Treating Gynecological Malignant Tumor
        20.  Analysis on the Efficacy of KLT Combined with Chemotherapy in the Treatment of Advanced Malignancy
        21. Observation on Safety of Kanglaite Injection in Treating Senile Patients with Advanced Tumor 
        22. A Clinical Study of Kanglaite Injection Combined with Radiotherapy in the Management of Malignant Tumors
        23. Clinical Observation on Kanglaite Injection in the Treatment of Advanced Cancer Failed in Previous Chemotherapy
        24. Clinical Observation on Kanglaite Injection plus Combined Chemotherapy in the Treatment of Acute Leukemia
        25. Kanglaite Injection Combined with HAD Regimen in the Treatment of Adult Acute Non-Lymphocytic Leukemia
         
        E. KLT Application in the Treatment of Cancerous Pain
        1. Summary of Phase III Clinical Trial of Kanglaite Injection on Relief of Cancerous Pain and Improvement of Life Quality in Patients with Advanced Cancer
        2. Clinical Observation on the Effect of Kanglaite Injection in the Treatment of Cancerous Pain
        3. Clinical Report on Kanglaite Injection (KLT) in Improving Cancer Patients' Quality of Life
        4. Clinical Observation on the Effect of Kanglaite Injection on the Survival Quality of Senile Patients with Advanced Cancer

        F. KLT Application in the Treatment of Ascites
        1. Indwelling Microcatheter in the Treatment of Cancerous Ascites
        2. Observation on Paclitaxel Intraperitoneal Chemotherapy Combined with Kanglaite Injection in Treating Malignant Ascites of Advanced Hepatic Carcinoma
        3. Clinical Study on Sequential Application of Kanglaite Injection (KLT) and thrombin in Treating Cancerous Pleural Effusion
        4. Clinical Study on Kanglaite Injection in the Treatment of Malignant Pleural Effusion